Recent research indicates that semaglutide, a drug used for weight loss, may also extend lifespan and improve health measures in elderly mice. While the findings are intriguing, they do not confirm similar effects in humans and require further investigation to understand the imp…
A recent analysis reveals that prescription rates for GLP-1 weight-loss medications, such as Wegovy and Mounjaro, are significantly lower in England's most deprived areas, despite…
Recent studies indicate that GLP-1 obesity injections, including Ozempic and Mounjaro, may not be effective for all individuals, with some participants failing to achieve signific…
As GLP-1 medications gain popularity for weight loss, many users face the dilemma of whether they can stop the injections without regaining weight. Experts highlight the risks ass…
The Korean Society for the Study of Obesity (KSSO) recently convened a policy session to address the significant socioeconomic costs associated with obesity in South Korea, estima…
A study published in Nature suggests that GLP-1 obesity drugs, such as semaglutide, may extend lifespan and improve health in older female mice. The research indicates that treate…
Researchers at the University of California, Berkeley, have identified an oral compound named TOFA that significantly reduces body weight in obese mice by boosting energy expendit…
A recent study published in Cell Metabolism suggests that while ketogenic, Mediterranean, and low-fat diets can support weight loss, the ketogenic diet may provide additional bene…
This article examines the potential of GLP-1 receptor agonists, commonly used for type 2 diabetes and obesity, in treating polyendocrine metabolic ovarian syndrome (PMOS). Experts…
The first generic weight loss medication has been launched in South Africa, sparking discussions about its affordability and accessibility. Mia Malan, founder of the Bhekisisa hea…
A study published in Science Advances reveals that the experimental drug TOFA enables obese mice to lose fat without reducing their food intake or losing muscle mass. The compound…
Health and Human Services Secretary Robert F. Kennedy Jr. has recently claimed a 3% drop in obesity rates, attributing it partially to the Trump administration's policies. However…